285 related articles for article (PubMed ID: 25913118)
21. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
Esirden İ; Ulus R; Aday B; Tanç M; Supuran CT; Kaya M
Bioorg Med Chem; 2015 Oct; 23(20):6573-80. PubMed ID: 26422787
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII.
Rami M; Winum JY; Innocenti A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2008 Jan; 18(2):836-41. PubMed ID: 18042384
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and carbonic anhydrase inhibitory properties of novel 4-(2-aminoethyl)benzenesulfonamide-dipeptide conjugates.
Küçükbay H; Buğday N; Küçükbay FZ; Berrino E; Bartolucci G; Del Prete S; Capasso C; Supuran CT
Bioorg Chem; 2019 Mar; 83():414-423. PubMed ID: 30419497
[TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
25. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives.
Abdel-Aziz AA; El-Azab AS; Bua S; Nocentini A; Abu El-Enin MA; Alanazi MM; AlSaif NA; Hefnawy MM; Supuran CT
Bioorg Chem; 2019 Jun; 87():425-431. PubMed ID: 30921744
[TBL] [Abstract][Full Text] [Related]
28. Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors.
Akocak S; Lolak N; Bua S; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1575-1580. PubMed ID: 30296852
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors.
Ceruso M; Antel S; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(2):205-11. PubMed ID: 25792500
[TBL] [Abstract][Full Text] [Related]
30. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties.
Sethi KK; Verma SM; Tanç M; Purper G; Calafato G; Carta F; Supuran CT
Bioorg Med Chem; 2014 Mar; 22(5):1586-95. PubMed ID: 24513184
[TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.
Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT
J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190
[TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
[TBL] [Abstract][Full Text] [Related]
33. Benzenesulfonamides incorporating bulky aromatic/heterocyclic tails with potent carbonic anhydrase inhibitory activity.
Bozdag M; Alafeefy AM; Vullo D; Carta F; Dedeoglu N; Al-Tamimi AM; Al-Jaber NA; Scozzafava A; Supuran CT
Bioorg Med Chem; 2015 Dec; 23(24):7751-64. PubMed ID: 26639945
[TBL] [Abstract][Full Text] [Related]
34. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.
Eldehna WM; Fares M; Ceruso M; Ghabbour HA; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA; Supuran CT
Eur J Med Chem; 2016 Mar; 110():259-66. PubMed ID: 26840366
[TBL] [Abstract][Full Text] [Related]
35. Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII.
Supuran CT; Maresca A; Gregáň F; Remko M
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):289-93. PubMed ID: 22299577
[TBL] [Abstract][Full Text] [Related]
36. Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds.
Abdel-Aziz AA; El-Azab AS; Ceruso M; Supuran CT
Bioorg Med Chem Lett; 2014 Nov; 24(22):5185-9. PubMed ID: 25442309
[TBL] [Abstract][Full Text] [Related]
37. Dendrimers incorporating benzenesulfonamide moieties strongly inhibit carbonic anhydrase isoforms I-XIV.
Carta F; Osman SM; Vullo D; AlOthman Z; Supuran CT
Org Biomol Chem; 2015 Jun; 13(23):6453-7. PubMed ID: 25976058
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.
Zimmerman S; Innocenti A; Casini A; Ferry JG; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(24):6001-6. PubMed ID: 15546717
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of aminocyanopyrazoles via a multi-component reaction and anti-carbonic anhydrase inhibitory activity of their sulfamide derivatives against cytosolic and transmembrane isoforms.
Allouche F; Chabchoub F; Carta F; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):343-9. PubMed ID: 23013533
[TBL] [Abstract][Full Text] [Related]
40. Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors.
Saczewski F; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Sep; 16(18):4846-51. PubMed ID: 16809036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
